Somewhat Favorable Media Coverage Extremely Likely to Affect Widecells Group (LON:WDC) Stock Price

News coverage about Widecells Group (LON:WDC) has been trending somewhat positive this week, InfoTrie Sentiment reports. The research group rates the sentiment of news coverage by analyzing more than 6,000 blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Widecells Group earned a daily sentiment score of 0.86 on their scale. InfoTrie also gave media coverage about the company an news buzz score of 10 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock’s share price in the next few days.

Shares of LON:WDC opened at GBX 0.31 ($0.00) on Friday. Widecells Group has a 12 month low of GBX 0.15 ($0.00) and a 12 month high of GBX 2.98 ($0.04). The firm has a market capitalization of $3.07 million and a price-to-earnings ratio of -0.06. The stock’s 50-day moving average price is GBX 0.34.

About Widecells Group

WideCells Group PLC operates as an integrated stem cell support services company worldwide. It operates through three divisions: CellPlan, WideCells, and WideAcademy. The CellPlan division provides insurance products and finance solutions for the cord blood stem cell transplantation. The WideCells division offers collection, stem cell retrieval, processing, and storage services of umbilical cord blood and tissue, adipose tissue, and dental pulp under the BabyCells brand Portugal.

Further Reading: Day Trading

Receive News & Ratings for Widecells Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Widecells Group and related companies with MarketBeat.com's FREE daily email newsletter.